 |
市場調查報告書
商品編碼
1671893
全球威爾遜氏症治療市場依治療類型、給藥途徑、年齡層、通路及地區分類Wilson's Disease Treatment Market, By Type of Treatment, By Route of Administration, By Age Group, By Distribution Channel, By Geography |
||||||
2025 年全球威爾遜氏症治療市場規模估計為 6.308 億美元，預計到 2032 年將達到 9.932 億美元，2025 年至 2032 年的複合年成長率為 6.7%。
| 報告範圍 | 報告詳細資訊 | ||
|---|---|---|---|
| 基準年 | 2024 | 2025 年市場規模 | 6.308億美元 |
| 效能資料 | 2020-2024 | 預測期 | 2025-2032 |
| 預測期：2025-2032年複合年成長率： | 6.70% | 2032 年價值預測 | 9.932億美元 |
威爾遜氏症是一種罕見的遺傳疾病，會導致銅在肝臟和大腦等其他重要器官中積聚。它會影響身體透過膽汁和尿液釋放銅的能力。如果不及時治療，威爾遜氏症可能會導致嚴重的健康問題，甚至死亡。然而，透過正確的診斷和治療，患者的預期壽命可以顯著提高。隨著全世界對該疾病的認知不斷提高，越來越多的患者得到診斷並接受有效治療。預計這將推動預測期內全球威爾遜氏症治療市場的穩定成長。
市場動態：
由於疾病意識的提高和新診斷的增加，全球威爾遜氏症治療市場預計將適度成長。新型治療劑的開發也有望提供機會。然而，由於銅螯合劑是罕見疾病的治療方法，其高成本可能會阻礙市場擴張。此外，開發中國家對該疾病的認知度低也也是一項挑戰。然而，自願組織和政府支持計畫的舉措可能有助於解決負擔能力問題並改善診斷，特別是在中低收入國家。
本研究的主要特點
本報告對全球威爾遜氏症治療市場進行了詳細分析，並以 2024 年為基準年，給出了預測期（2025-2032 年）的市場規模和年複合成長率（CAGR%）。
它還強調了各個領域的潛在商機並說明了該市場的有吸引力的投資提案矩陣。
它還提供了對市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景以及主要企業採用的競爭策略的重要見解。
全球威爾遜氏症治療市場的主要企業是根據公司亮點、產品系列、關鍵亮點、績效和策略等參數列出的。
研究中涉及的主要企業包括 Valeant Pharmaceuticals International、Merck &Co、Tsumura &Co、VHB Life Science Inc.、Teva Pharmaceuticals USA Inc.、Wilson's Therapeutics AB、Noble Pharma Co.Ltd.、Kadmon Holdings Inc.、Zydus Cadila、Sururolan NV、Sasam、Mimom、ASk、Amoions）
從本報告中獲得的見解將使負責人和公司經營團隊能夠就未來的產品發布、升級、市場擴張和行銷策略做出明智的決策。
全球威爾遜氏症治療市場報告針對該行業的各個相關人員，包括投資者、供應商、產品製造商、經銷商、新進業者和金融分析師。
相關人員將透過用於分析全球威爾遜氏症治療市場的各種策略矩陣更輕鬆地做出決策。
目錄
第1章 調查目的與前提條件
- 研究目標
- 先決條件
- 簡稱
第2章 市場展望
- 報告描述
- 市場定義和範圍
- 執行摘要
第3章市場動態、法規與趨勢分析
- 市場動態
- 影響分析
- 主要進展
- 監管情景
- 產品發布/核准
- PEST分析
- 波特的分析
- 併購情景
- 產業趨勢
4. 全球威爾遜氏症治療市場按治療類型分類（2020-2032 年）
- 藥物治療
- 肝臟移植
- 飲食管理
5. 全球威爾遜氏症治療市場依給藥途徑分類（2020-2032 年）
- 口服
- 腸外
- 其他
6. 全球威爾遜氏症治療市場按年齡層分類（2020-2032 年）
- 孩子
- 成人
- 老年人
7. 全球威爾遜氏症治療市場按通路分類（2020-2032 年）
- 院內藥房
- 零售藥局
- 網路藥局
8. 全球威爾遜氏症治療市場按地區分類（2020-2032 年）
- 北美洲
- 拉丁美洲
- 歐洲
- 亞太地區
- 中東
- 非洲
第9章 競爭格局
- Valeant Pharmaceuticals International
- Merck & Co
- Tsumura & Co
- VHB Life Science Inc.
- Teva Pharmaceuticals USA Inc.
- Wilson's Therapeutics AB
- Noble Pharma Co. Ltd
- Kadmon Holdings Inc.
- Zydus Cadila
- Mylan NV
- Hikma Pharmaceuticals
- Sandoz（a Novartis division）
- Aurobindo Pharma
- Amgen Inc.
- Pfizer Inc.
第 10 章分析師建議
- 命運之輪
- 分析師觀點
- Coherent Opportunity Map（COM）
第 11 章 參考文獻與調查方法
- 參考
- 調查方法
- 關於出版商
Wilson's Disease Treatment Market is estimated to be valued at US$ 630.8 Mn in 2025 and is expected to reach US$ 993.2 Mn by 2032, growing at a compound annual growth rate (CAGR) of 6.7% from 2025 to 2032.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2024 | Market Size in 2025: | US$ 630.8 Mn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2025 To 2032 |
| Forecast Period 2025 to 2032 CAGR: | 6.70% | 2032 Value Projection: | US$ 993.2 Mn |
Wilson's disease is a rare genetic disorder that causes copper to accumulate in the liver and other vital organs like the brain. It affects the ability of the body to release copper through bile and urine. Untreated Wilson's disease can cause serious medical problems and may become fatal. However, with proper diagnosis and treatment, life expectancy of patients can be improved significantly. As awareness about this condition is rising globally, more patients are being diagnosed and treated effectively. This is expected to drive steady growth in the global Wilson's disease treatment market during the forecast period.
Market Dynamics:
The global Wilson's disease treatment market is anticipated to witness moderate growth attributed to rising disease awareness and new diagnosis. Development of novel drugs for treatment is also expected to provide opportunities. However, high costs associated with copper-chelating agents, being orphan drugs, can hamper market expansion to some extent. Additionally, lack of disease awareness in developing nations poses a challenge. Nonetheless, initiatives by voluntary organizations as well as government support programs can help address affordability issues and improve diagnosis especially in low-and middle-income countries.
Key Features of the Study:
This report provides in-depth analysis of the global Wilson's disease treatment market, and provides market size (USD Mn) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global Wilson's disease treatment market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Valeant Pharmaceuticals International, Merck & Co, Tsumura & Co, VHB Life Science Inc., Teva Pharmaceuticals USA Inc., Wilson's Therapeutics AB, Noble Pharma Co. Ltd, Kadmon Holdings Inc., Zydus Cadila, Mylan N.V., Hikma Pharmaceuticals, Sandoz (a Novartis division), Aurobindo Pharma, Amgen Inc., and Pfizer Inc.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global Wilson's disease treatment market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global Wilson's disease treatment market
Market Segmentation
- By Type of Treatment Insights (Revenue, USD Mn, 2020 - 2032)
- Pharmacological Treatment
- Chelation Therapy
- Zinc Therapy
- Liver Transplantation
- Dietary Management
- By Route of Administration Insights (Revenue, USD Mn, 2020 - 2032)
- Oral
- Parenteral
- Others
- By Age Group Insights (Revenue, USD Mn, 2020 - 2032)
- Pediatric
- Adult
- Geriatric
- By Distribution Channel Insights (Revenue, USD Mn, 2020 - 2032)
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Regional Insights (Revenue, USD Mn, 2020 - 2032)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Key Players Insights
- Valeant Pharmaceuticals International
- Merck & Co
- Tsumura & Co
- VHB Life Science Inc.
- Teva Pharmaceuticals USA Inc.
- Wilson's Therapeutics AB
- Noble Pharma Co. Ltd
- Kadmon Holdings Inc.
- Zydus Cadila
- Mylan N.V.
- Hikma Pharmaceuticals
- Sandoz (a Novartis division)
- Aurobindo Pharma
- Amgen Inc.
- Pfizer Inc.
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Global Wilson's Disease Treatment Market, By Type of Treatment
- Global Wilson's Disease Treatment Market, By Route of Administration
- Global Wilson's Disease Treatment Market, By Age Group
- Global Wilson's Disease Treatment Market, By Distribution Channel
- Global Wilson's Disease Treatment Market, By Region
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Driver
- Restraint
- Opportunity
- Impact Analysis
- Key Developments
- Regulatory Scenario
- Product Launches/Approvals
- PEST Analysis
- PORTER's Analysis
- Merger and Acquisition Scenario
- Industry Trends
4. Global Wilson's Disease Treatment Market, By Type of Treatment, 2020-2032, (USD Mn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Pharmacological Treatment
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
- Liver Transplantation
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
- Dietary Management
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
5. Global Wilson's Disease Treatment Market, By Route of Administration, 2020-2032, (USD Mn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Oral
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
- Parenteral
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
6. Global Wilson's Disease Treatment Market, By Age Group, 2020-2032, (USD Mn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Pediatric
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
- Adult
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
- Geriatric
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
7. Global Wilson's Disease Treatment Market, By Distribution Channel, 2020-2032, (USD Mn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Hospital Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
- Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
- Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
8. Global Wilson's Disease Treatment Market, By Region, 2020 - 2032, Value (USD Mn)
- Introduction
- Market Share (%) Analysis, 2025,2028 & 2032, Value (USD Mn)
- Market Y-o-Y Growth Analysis (%), 2021 - 2032, Value (USD Mn)
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, By Type of Treatment, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Route of Administration, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Age Group , 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Mn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, By Type of Treatment, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Route of Administration, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Mn)
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, By Type of Treatment, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Route of Administration, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Age Group , 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Mn)
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, By Type of Treatment, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Route of Administration, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Age Group , 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Mn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, By Type of Treatment, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Route of Administration, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Age Group , 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Mn)
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, By Type of Treatment, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Route of Administration, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Age Group , 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Country/Region, 2020 - 2032, Value (USD Mn)
- South Africa
- North Africa
- Central Africa
9. Competitive Landscape
- Valeant Pharmaceuticals International
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Merck & Co
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Tsumura & Co
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- VHB Life Science Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Teva Pharmaceuticals USA Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Wilson's Therapeutics AB
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Noble Pharma Co. Ltd
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Kadmon Holdings Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Zydus Cadila
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Mylan N.V.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Hikma Pharmaceuticals
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Sandoz (a Novartis division)
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Aurobindo Pharma
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Amgen Inc.
- Pfizer Inc.
10. Analyst Recommendations
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
11. References and Research Methodology
- References
- Research Methodology
- About us
